Clinical Development & Operations
End-to-end clinical execution backed by experience and intelligence.
From first-in-human to global late phase, UNIQ delivers clinical programs built on precision, agility, and partnership.
Clinical Development & Operations
End-to-end clinical execution backed by experience and intelligence.
From first-in-human to global late phase, uNIQ delivers
clinical programs built on precision, agility, and partnership.
Accelerate your clinical development program with UNIQ
Our global clinical development and operations teams guide biotech innovators through every stage of the trial lifecycle.
We combine predictive feasibility, adaptive trial design, and a culture of transparency to deliver consistent results — faster.
Whether your goal is speed to proof-of-concept or quality for pivotal trials, we integrate science, data, and people to make it happen.
- Feasibility assessment and site selection
- Protocol development& CRF design
- Patient recruitment strategie
- Ethics Committee and Regulatory submissions
- Project management and monitoring for Phase I-IV trials
- Third party vendor management
- Medical, technical and CSR writing.
Early Phase Excellence
Smart beginnings. Solid outcomes.
Early-phase execution defines the success of every program. UNIQ’s Phase I–II capabilities focus on adaptive design, biomarker integration, and precision patient recruitment.
Our early-phase units and trusted partner sites across global regions ensure smooth transitions from lab to clinic — helping you reach proof-of-concept faster.
Every decision is guided by data intelligence — from feasibility forecasting to real-time dose escalation dashboards.
Predictive insights. Faster activation.
We merge analytics with human expertise to choose the right sites the first time.
unIQ Trials’s proprietary feasibility models draw from geographic recruitment data, investigator performance history, and protocol complexity.
Start-up doesn’t have to mean slow. Our country-specific teams streamline regulatory submissions, contract negotiations, and ethics approvals — reducing average activation times by up to 30%.
Feasibility & Site Start-Up
Predictive insights. Faster activation.
We merge analytics with human expertise to choose the right sites the first time. unIQ’s proprietary feasibility models draw from geographic recruitment data, investigator performance history, and protocol complexity.
Start-up doesn’t have to mean slow. Our country-specific teams streamline regulatory submissions, contract negotiations, and ethics approvals — reducing average activation times by up to 25%.
Monitoring & Oversight
Risk-based monitoring, powered by real-time data.
We integrate centralized and on-site monitoring with unified dashboards that show enrollment, deviations, and site KPIs in real time.
Our hybrid oversight approach balances technology and human expertise — ensuring patient safety and data integrity without unnecessary site visits.
UNIQ’S monitoring = proactive, transparent, and inspection-ready.
Study Closeout & Reporting
The finish line, redefined.
Our closeout teams manage last-patient-last-visit through CSR submission seamlessly.
Automated tracking ensures every data point, deviation, and deliverable is finalized with zero lag.
From database lock to clinical study reports (CSRs), we guarantee precision, compliance, and audit-ready documentation.